These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30681565)

  • 1. Efficacy of infantile hepatic hemangioma with propranolol treatment: A case report.
    Tsai MC; Liu HC; Yeung CY
    Medicine (Baltimore); 2019 Jan; 98(4):e14078. PubMed ID: 30681565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.
    Cavalli R; Novotna V; Buffon RB; Gelmetti C
    G Ital Dermatol Venereol; 2013 Oct; 148(5):525-30. PubMed ID: 24005146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
    Mhanna A; Franklin WH; Mancini AJ
    Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of propranolol in the treatment of parotid hemangioma.
    Morais P; Magina S; Mateus M; Trindade E; Jesus JM; Azevedo F
    Cutan Ocul Toxicol; 2011 Sep; 30(3):245-8. PubMed ID: 21338243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature.
    Bosemani T; Puttgen KB; Huisman TA; Tekes A
    Eur J Pediatr; 2012 Jul; 171(7):1023-8. PubMed ID: 22234480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infantile hepatic hemangiomas: first-line propranolol monotherapy as new treatment strategy?].
    Baranowski S; Winkler A; Kunzi-Rapp K; Schaal M; Hempel S; Debatin KM; Posovszky C
    Klin Padiatr; 2012 Oct; 224(6):393-5. PubMed ID: 23143767
    [No Abstract]   [Full Text] [Related]  

  • 7. "Cyrano nose" associated with hepatic hemangiomas successfully treated with propranolol.
    Vergine G; Sorci M; Rosafio C; Bigucci B; Filippini B; Ancora G
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review.
    Kang E; Friedman N; Mamoun I; Tamburro J; Golden A
    Pediatr Neurol; 2016 Jun; 59():13-7. PubMed ID: 27068061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of propranolol treatment in thyroid dysfunction associated with severe infantile hepatic hemangioma.
    Vergine G; Marsciani A; Pedini A; Brocchi S; Marsciani M; Desiderio E; Bertelli S; Vecchi V
    Horm Res Paediatr; 2012; 78(4):256-60. PubMed ID: 22907522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of propranolol therapy in Moroccan children with infantile hemangioma.
    Lahrichi A; Hali F; Baline K; Fatoiki FZE; Chiheb S; Khadir K
    Arch Pediatr; 2018 Nov; 25(8):449-451. PubMed ID: 30361087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal giant hepatic hemangioma: A case report.
    Zhu Z; Cai P; Zhu J; Chen J; Wu B; Gu Z; Huang S; Wang J
    Medicine (Baltimore); 2018 Oct; 97(42):e12863. PubMed ID: 30334996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
    Kagami S; Kaneko M; Kishi A; Katori T
    J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
    López-Gutiérrez JC
    Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High-Dose Propranolol.
    Warren D; Diaz L; Levy M
    Pediatr Dermatol; 2017 Sep; 34(5):e286-e287. PubMed ID: 28730754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical and Contemporary Management of Infantile Hepatic Hemangioma: A 30-year Single-center Experience.
    Macdonald A; Durkin N; Deganello A; Sellars ME; Makin E; Davenport M
    Ann Surg; 2022 Jan; 275(1):e250-e255. PubMed ID: 33064395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
    Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
    J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Consumptive Hypothyroidism in a 1-Month-Old Boy with Diffuse Infantile Hepatic Hemangiomas.
    Kim YH; Lee YA; Shin CH; Hong KT; Kim GB; Ko JS; Lee YJ
    J Korean Med Sci; 2020 Jun; 35(22):e180. PubMed ID: 32508067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile Hemangiomas: Pathogenesis and Review of Propranolol Use.
    Laken PA
    Adv Neonatal Care; 2016 Apr; 16(2):135-42. PubMed ID: 26945282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.